PubMed

Pharmacologic therapy for type 2 diabetes mellitus.

DeFronzo RA.

Ann Intern Med. 2000 Jul 4;133(1):73-4. No abstract available. PMID: 10877745 [PubMed - indexed for MEDLINE]Related articlesFree article

Rosiglitazone approved for treatment of type 2 diabetes.

Miller JL.

Am J Health Syst Pharm. 1999 Jul 1;56(13):1292, 1294. No abstract available. PMID: 10683120 [PubMed - indexed for MEDLINE]Related articles

Anticipated US approval for rosiglitazone and pioglitazone.

[No authors listed]

Diabetes Obes Metab. 1999 May;1(3):181-2. No abstract available. PMID: 11220298 [PubMed - indexed for MEDLINE]Related articles

Diabetes recall. Though Rezulin's withdrawal is a blow for some patients, there are ways to cope. Here's how.

Gorman C.

Time. 2000 Apr 3;155(13):94. No abstract available. PMID: 11009709 [PubMed - indexed for MEDLINE]Related articles

FDA approves pioglitazone for diabetes.

Miller JL.

Am J Health Syst Pharm. 1999 Sep 1;56(17):1698. No abstract available. PMID: 10512494 [PubMed - indexed for MEDLINE]Related articles

From the Food and Drug Administration.

Henney JE.

JAMA. 1999 Sep 8;282(10):932. No abstract available. PMID: 10485665 [PubMed - indexed for MEDLINE]Related articles

Warner Lambert/Sankyo diabetes drug nears market.

[No authors listed]

Nat Biotechnol. 1997 Feb;15(2):113. No abstract available. PMID: 9035120 [PubMed - indexed for MEDLINE]Related articles

[Oral therapy in type 2 diabetes. Critical evaluation of glitazones]

Lotz N.

MMW Fortschr Med. 2002 Jan 24;144(3-4):48-50. German. No abstract available. PMID: 11862793 [PubMed - indexed for MEDLINE]Related articles

[First insulin sensitizer approved in Germany. Insulin resistance in type 2 diabetes can be treated]

[No authors listed]

MMW Fortschr Med. 2000 Sep 7;142(36):50. German. No abstract available. PMID: 11021073 [PubMed - indexed for MEDLINE]Related articles

Lessons from the Avandia controversy: a new paradigm for the development of drugs to treat type 2 diabetes.

Misbin RI.

Diabetes Care. 2007 Dec;30(12):3141-4. Review. No abstract available. PMID: 18042753 [PubMed - indexed for MEDLINE]Related articlesFree article

Constructing an algorithm for managing type 2 diabetes. Focus on role of the thiazolidinediones.

Wyne KL, Drexler AJ, Miller JL, Bell DS, Braunstein S, Nuckolls JG.

Postgrad Med. 2003 May;Spec No:63-72. Review.PMID: 12785133 [PubMed - indexed for MEDLINE]Related articles

Major US consumer group asks FDA to ban drug for diabetes.

Tanne JH.

BMJ. 2008 Nov 5;337:a2401. doi: 10.1136/bmj.a2401. No abstract available. PMID: 18987042 [PubMed - indexed for MEDLINE]Related articles

Rosiglitazone and the FDA.

Joffe HV, Parks MH, Meyer RJ, Jenkins JK, Temple R.

N Engl J Med. 2007 Oct 25;357(17):1775-6; author reply 1777. Epub 2007 Aug 29. No abstract available. PMID: 17761586 [PubMed - indexed for MEDLINE]Related articles

Rosiglitazone and the FDA.

Krall RL.

N Engl J Med. 2007 Oct 25;357(17):1776-7; author reply 1777. No abstract available. PMID: 17969232 [PubMed - indexed for MEDLINE]Related articles

Rosiglitazone monotherapy and type 2 diabetes.

Lawrence IG.

Diabet Med. 2001 Nov;18 Suppl 4:6-8. No abstract available. PMID: 11989215 [PubMed - indexed for MEDLINE]Related articles

The rosiglitazone story--lessons from an FDA Advisory Committee meeting.

Rosen CJ.

N Engl J Med. 2007 Aug 30;357(9):844-6. Epub 2007 Aug 8. No abstract available. PMID: 17687124 [PubMed - indexed for MEDLINE]Related articles

The clinical effectiveness and cost-effectiveness of pioglitazone for type 2 diabetes mellitus: a rapid and systematic review.

Chilcott J, Wight J, Lloyd Jones M, Tappenden P.

Health Technol Assess. 2001;5(19):1-61. Review. No abstract available. PMID: 11701097 [PubMed - indexed for MEDLINE]Related articlesFree article

[Thiazolidinediones in type 2 diabetes]

Baum U.

Med Monatsschr Pharm. 2000 Jul;23(7):210-3. German. No abstract available. PMID: 10941251 [PubMed - indexed for MEDLINE]Related articles

Avandia, a leading alternative for Rezulin patients, prescribed to more than 700,000 patients.

[No authors listed]

Diabetes Technol Ther. 2000 Summer;2(2):292. No abstract available. PMID: 11469275 [PubMed - indexed for MEDLINE]Related articles

Rezulin to be withdrawn from the market.

[No authors listed]

Diabetes Technol Ther. 2000 Summer;2(2):289. No abstract available. PMID: 11469272 [PubMed - indexed for MEDLINE]Related articles